Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
SARS-CoV-2에 대한 5가지 면역분석의 성능 특성: 일대일 벤치마크 비교
Comparative Study
Published on
Journal: The Lancet. Infectious Diseases
[Category] Communicable Disease, MERS, SARS, 진단,
Journal: The Lancet. Infectious Diseases
[Category] Communicable Disease, MERS, SARS, 진단,
[키워드] (Abbott
384-well ELISA
95% CI
Abbott
acute respiratory syndrome
acute respiratory syndrome coronavirus
Basel
benchmark study
benefit
best
blood sample
Blood samples
can be used
caused
Characteristics
Chicago
collected
coronavirus
DiaSorin
Effects
Elecsy
Elecsys
finding
FIVE
funding
Germany
global pandemic
head
head-to-head assessment
Health
IgG
immunoassay
individual
Italy
laboratory-confirmed SARS-CoV-2 infection
LIAISON
Metrics
Munich
novel
Oxford
Oxford immunoassay
Patient
performance
public health
Public Health England
receiver operating characteristic
resource
respiratory
risk
Risk assessment
ROC
Roche
S1/S2
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 IgG
SARS-COV-2 infection
sensitivity
Sensitivity and specificity
Serological testing
serology
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
Siemen
Siemens
specificity
Surveillance
Switzerland
symptom onset
Testing
threshold
thresholds
Total
USA
were used
[DOI] 10.1016/S1473-3099(20)30634-4 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1016/S1473-3099(20)30634-4 PMC 바로가기 [Article Type] Comparative Study